When a clinical trial ends, the data does not automatically become public knowledge. A multi-step process transforms raw study data into the peer-reviewed publications that inform medical practice, and understanding this process helps patients appreciate both the rigor and the limitations of published evidence.
From Raw Data to Published Science
Data cleaning and locking. After the last participant completes the study, the data management team reviews all submitted data for errors, inconsistencies, and missing values. Once quality is confirmed, the database is “locked”, no further changes can be made.
Statistical analysis. Biostatisticians analyze the data according to the pre-specified statistical analysis plan (SAP). The primary endpoint is evaluated first. Secondary endpoints, subgroup analyses, and safety analyses follow. The SAP was finalized before unblinding, preventing the manipulation of analysis choices based on what the data shows.
Report writing. A clinical study report (CSR) is written by the sponsor summarizing all aspects of the study design, conduct, and results. CSRs submitted to the FDA are typically several thousand pages long.
Manuscript preparation. A subset of the CSR is prepared as a peer-reviewed manuscript. The investigator team and sponsor contribute to writing, and lead authorship typically goes to the principal investigator who led a major enrollment site or the scientific leader of the program.
Peer review. The manuscript is submitted to a medical journal where it is reviewed by independent scientists with relevant expertise. Peer reviewers may request revisions, additional analyses, or clarification before accepting the manuscript for publication.
Publication Bias
One significant limitation: studies with positive results are substantially more likely to be published than those with negative results. This means the published literature over-represents evidence that treatments work, relative to the full evidence base including failed studies. Registration of trials on ClinicalTrials.gov before they begin helps track whether all studies, including negative ones, eventually report results.
Results Reporting Requirements
Federal law (FDAAA 801) requires that most clinical trials registered on ClinicalTrials.gov report summary results within 12 months of the primary completion date, whether or not results are published in a journal.
Participate in NuLine’s research and contribute to the published evidence base.